UnitedHealth faces IRS fight over foreign subsidiary transactions and potential tax bill
The IRS is seeking to increase UnitedHealth’s taxable income over foreign subsidiary transactions as the healthcare giant contests the proposed tax adjustments.
UnitedHealth Group is clashing with the Internal Revenue Service (IRS) over tax adjustments they propose for transactions involving a foreign subsidiary spanning from 2017 to 2020. The dispute centers on transfer pricing, the methodology used by multinational corporations to price transactions between related businesses in different countries.
The IRS believes these prices may not have been set appropriately, potentially leading to increased taxable income for UnitedHealth. The company has not identified the affected subsidiary or quantified the additional tax sought by the IRS. UnitedHealth maintains its disagreement with the proposed adjustments, stating it plans to contest them vigorously.
This issue is part of a broader trend of increased IRS scrutiny of US-based multinational corporations' profit allocation between domestic and overseas operations. Similar disputes have involved companies such as Coca-Cola, Meta, and Medtronic, with some cases involving billions of dollars in tax and interest. The potential liability in UnitedHealth's case remains unclear, as the IRS has not disclosed the specifics of the proposed adjustments or the final tax assessment.
Written by urgent.news from Live Mint's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
